FDA seeks further action on manufacturing problems at Genzyme plant

03/24/2010 | Boston Herald · MarketWatch

The FDA intends to "take enforcement action" that might involve hiring a third-party inspection team to investigate manufacturing processes at Genzyme's plant in Allston, Mass., in light of recurring problems. Genzyme Chairman Henri Termeer said the biotech firm is "truly advancing in the recovery of the Allston plant."

View Full Article in:

Boston Herald · MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR